ftInvstr
AMANTA · Healthcare ₹202.5 -0.32% Mkt Cap ₹784 Cr

AMANTA

Healthcare Drug Manufacturers - Specialty & Generic
₹202.5
-0.32% today · 30d +8.33%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for AMANTA. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹83 Cr
+17.27% YoY
NET PROFIT
₹5 Cr
+302.53% YoY
OPM
21.4%
+0.65pp YoY
EPS
₹1.25
PE 47.12
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-4.0% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
AMANTA47.12—
SUNPHARMA37.7921.44
DIVISLAB93.121.56
ZYDUSLIFE28.424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
72
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 100
Valuation FAIR 40
Growth STEADY 67
Profitability HIGH 75
Technicals STRONG 70
Risk LOW 80
Key Stats
TTM PE
47.12
P/B
3.34
52W HIGH
₹209.95
OFF HIGH
-3.55%
DIV YIELD
0.0%
MKT CAP
₹784 Cr
◉ Active Signals
MACDBullish4.721
RSI(14)Bullish63.99
Near 52W HighBullish-3.55
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold AMANTA and at what entry.

Sign up freeSign in